Darbepoetin alfa exerts a cardioprotective effect in autoimmune cardiomyopathy via reduction of ER stress and activation of the PI3K/Akt and STAT3 pathways

被引:58
作者
Mao, Weike [1 ]
Iwai, Chikao [1 ]
Liu, Jiahao [1 ]
Sheu, Shey-Shing [2 ]
Fu, Michael [3 ]
Liang, Chang-seng [1 ]
机构
[1] Univ Rochester, Med Ctr, Div Cardiol, Dept Med, Rochester, NY 14642 USA
[2] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA
[3] Sahlgrens Univ Hosp, Wallenberg Lab Cardiovasc Res, S-41345 Gothenburg, Sweden
关键词
cardiomyocyte apoptosis; endoplasmic reticulum; MAP kinases; Akt; Bcl2; Bax;
D O I
10.1016/j.yjmcc.2008.05.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dilated human cardiomyopathy is associated with suppression of the prosurvival phospliatidylinositol-3-kinase (PI3K)/Akt and STAT3 pathways. The present Study was carried out to determine if restoration of the PI3K/Akt and STAT3 activity by darbepoetin alfa improved cardiac function or reduced cardiomyocyte apoptosis in rabbit autoimmune cardiomyopathy induced by a peptide corresponding to the second extracellular loop of the beta(1)-adrenergic receptor (beta(1)-ECII). We found that beta(1)-ECII immunization produced progressive LV dilation, systolic dysfunction and myocyte apoptosis as measured by TUNEL, single-stranded DNA antibody, and active caspase-3. These changes were associated with activation of p38 mitogen-activated protein kinase (MAPK), endoplasmic reticulum stress markers (GRP78 and CHOP), and increased cleavage of procaspase-12, as well as decreased phosphorylation of Akt and STAT3, and decreased Bcl2/Bax ratio. As expected, darbepoetin alfa treatment increased phosphorylation of Akt and STAT3. It also increased the myocardial expression of erythropoietin receptor which was reduced in the failing myocardium, and improved cardiac function in the beta(1)-ECII-immunized animals. The latter was associated with reductions of myocyte apoptosis and cleaved caspase-3, as well as reversal of increased phosphorylation of p38-MAPK, increased ER stress, and decline in Bcl2/Bax ratio. The anti-apoptotic effects of darbepoetin alfa via Akt and STAT activation were also demonstrated in cultured cardiomyocytes treated with the anti-beta(1)-ECII antibody. These effects of darbepoetin alfa in vitro were prevented by LY294002 and STAT3 peptide inhibitor. Thus, we conclude that darbepoetin alfa improves cardiac function and prevents progression of dilated cardiomyopathy probably by activating the PI3K/Akt and STAT3 pathways and reducing ER stress. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:250 / 260
页数:11
相关论文
共 54 条
[1]  
Alberts B., 2008, MOL BIOL CELL, P695
[2]   Protective role of endogenous erythropoietin system in nonhematopoietic cells against pressure overload-induced left ventricular dysfunction in mice [J].
Asaumi, Yasuhide ;
Kagaya, Yutaka ;
Takeda, Morihiko ;
Yamaguchi, Nobuhiro ;
Tada, Hiroko ;
Ito, Kenta ;
Ohta, Jun ;
Shiroto, Takashi ;
Shirato, Kunio ;
Minegishi, Naoko ;
Shimokawa, Hiroaki .
CIRCULATION, 2007, 115 (15) :2022-2032
[3]   Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice [J].
Boengler, Kerstin ;
Buechert, Astrid ;
Heinen, Yvonne ;
Roeskes, Christin ;
Hilfiker-Kleiner, Denise ;
Heusch, Gerd ;
Schulz, Rainer .
CIRCULATION RESEARCH, 2008, 102 (01) :131-135
[4]   Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor [J].
Brines, M ;
Grasso, G ;
Fiordaliso, F ;
Sfacteria, A ;
Ghezzi, P ;
Fratelli, M ;
Latini, R ;
Xie, QW ;
Smart, J ;
Su-Rick, CJ ;
Pobre, E ;
Diaz, D ;
Gomez, D ;
Hand, C ;
Coleman, T ;
Cerami, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (41) :14907-14912
[5]   Stat3 as an oncogene [J].
Bromberg, JF ;
Wrzeszczynska, MH ;
Devgan, G ;
Zhao, YX ;
Pestell, RG ;
Albanese, C ;
Darnell, JE .
CELL, 1999, 98 (03) :295-303
[6]   Antibodies against the β1-adrenergic receptor induce progressive development of cardiomyopathy [J].
Buvall, Lisa ;
Tang, Margareta Scharin ;
Isic, Azra ;
Andersson, Bert ;
Fu, Michael .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 42 (05) :1001-1007
[7]  
CAMPANA WM, 1998, DEVELOPMENT, V1, P25
[8]   Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases [J].
Chong, ZZ ;
Kang, JQ ;
Maiese, K .
CIRCULATION, 2002, 106 (23) :2973-2979
[9]   STATs and gene regulation [J].
Darnell, JE .
SCIENCE, 1997, 277 (5332) :1630-1635
[10]   A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury [J].
Fiordaliso, F ;
Chimenti, S ;
Staszewsky, L ;
Bai, A ;
Carlo, E ;
Cuccovillo, I ;
Doni, M ;
Mengozzi, M ;
Tonelli, R ;
Ghezzi, P ;
Coleman, T ;
Brines, M ;
Cerami, A ;
Latini, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (06) :2046-2051